1. Home
  2. ALT vs CARE Comparison

ALT vs CARE Comparison

Compare ALT & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • CARE
  • Stock Information
  • Founded
  • ALT 1997
  • CARE 1974
  • Country
  • ALT United States
  • CARE United States
  • Employees
  • ALT N/A
  • CARE N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • CARE Major Banks
  • Sector
  • ALT Health Care
  • CARE Finance
  • Exchange
  • ALT Nasdaq
  • CARE Nasdaq
  • Market Cap
  • ALT 292.0M
  • CARE 396.9M
  • IPO Year
  • ALT N/A
  • CARE N/A
  • Fundamental
  • Price
  • ALT $3.83
  • CARE $19.46
  • Analyst Decision
  • ALT Strong Buy
  • CARE Buy
  • Analyst Count
  • ALT 6
  • CARE 2
  • Target Price
  • ALT $17.40
  • CARE $21.50
  • AVG Volume (30 Days)
  • ALT 3.0M
  • CARE 71.3K
  • Earning Date
  • ALT 08-12-2025
  • CARE 10-23-2025
  • Dividend Yield
  • ALT N/A
  • CARE N/A
  • EPS Growth
  • ALT N/A
  • CARE 154.06
  • EPS
  • ALT N/A
  • CARE 1.36
  • Revenue
  • ALT $20,000.00
  • CARE $153,120,000.00
  • Revenue This Year
  • ALT N/A
  • CARE $10.85
  • Revenue Next Year
  • ALT $761,880.20
  • CARE $14.12
  • P/E Ratio
  • ALT N/A
  • CARE $14.31
  • Revenue Growth
  • ALT N/A
  • CARE 21.78
  • 52 Week Low
  • ALT $2.90
  • CARE $13.61
  • 52 Week High
  • ALT $11.16
  • CARE $20.40
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • CARE 70.53
  • Support Level
  • ALT $3.35
  • CARE $18.42
  • Resistance Level
  • ALT $3.66
  • CARE $19.80
  • Average True Range (ATR)
  • ALT 0.19
  • CARE 0.43
  • MACD
  • ALT 0.07
  • CARE 0.11
  • Stochastic Oscillator
  • ALT 86.18
  • CARE 84.04

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: